An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study)
Phase of Trial: Phase IV
Latest Information Update: 08 Nov 2016
At a glance
- Drugs Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms SPEED Study
- 30 Oct 2016 Planned End Date changed from 1 Feb 2019 to 1 Dec 2018.
- 30 Oct 2016 Planned primary completion date changed from 1 Feb 2019 to 1 Dec 2018.
- 23 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.